Sporotrichosis pathophysiology
Sporotrichosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Sporotrichosis pathophysiology On the Web |
American Roentgen Ray Society Images of Sporotrichosis pathophysiology |
Risk calculators and risk factors for Sporotrichosis pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Alison Leibowitz [2]
Overview
Pathophysiology
Transmission
- S. schenckii is usually transmitted to the human host via posttraumatic inoculation. However, sporotrichosis may also develop as a result of spore inhalation, although this mode of transmission is infrequent.
- Modes of transmission either lead to direct inoculation or enable the entry of the fungus.
- Actions, such as handling thorny plants, sphagnum moss, bales of hay, or any plant or plant product that can cause skin trauma, may enable S. schenckii entry.
Pathogenesis
- The pathophysiology of sporotrichosis depends on the histological subtype and the frequently nonspecific histopathology may mimic other granulomatous diseases.[1]
Cutaneous forms
- S. schecknii accesses the subcutaneous tissue following minor epidermal trauma.
- S. schecknii, a thermo-dependent fungus, converts into its yeast form upon entering the tissue.
- Fixed form
- The yeast form of S. schenckii stays localized in subcutaneous tissue
- Lymphocutaneous form
- The yeast form of S. schenckii extends through the nearby lymphatic vessels
- Disseminated cutaneous form
- Manifests upon the hematogenous dissemination of the yeast form of S. schenckii.
Extracutaneous/Systematic Forms
- Osteoarticular form
- May manifest upon contiguity or hematogenous spread.
- Pulmonary form
- Disseminated form
References
- ↑ Mahajan VK (2014). "Sporotrichosis: an overview and therapeutic options". Dermatol Res Pract. 2014: 272376. doi:10.1155/2014/272376. PMC 4295339. PMID 25614735.